ATARA BIOTHERAPEUTICS, INC. Proceeds from Issuance of Convertible Preferred Stock
ATARA BIOTHERAPEUTICS, INC. (ATRA) reported Proceeds from Issuance of Convertible Preferred Stock of $0 for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-09.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock · last filed 2017-03-09
- ATARA BIOTHERAPEUTICS, INC. proceeds from issuance of convertible preferred stock for the quarter ending 2014-12-31 was -$19.00K, a 100.05% decline year-over-year.
- ATARA BIOTHERAPEUTICS, INC. proceeds from issuance of convertible preferred stock for the quarter ending 2014-09-30 was $0.00.
- ATARA BIOTHERAPEUTICS, INC. proceeds from issuance of convertible preferred stock for the quarter ending 2014-06-30 was $0.00.
- ATARA BIOTHERAPEUTICS, INC. proceeds from issuance of convertible preferred stock for the quarter ending 2014-03-31 was $13.50M.
- ATARA BIOTHERAPEUTICS, INC. proceeds from issuance of convertible preferred stock for fiscal 2016 was $0.00.
- ATARA BIOTHERAPEUTICS, INC. proceeds from issuance of convertible preferred stock for fiscal 2015 was $0.00, a 100.00% decline from fiscal 2014.
- ATARA BIOTHERAPEUTICS, INC. proceeds from issuance of convertible preferred stock for fiscal 2014 was $13.48M, a 74.74% decline from fiscal 2013.
- ATARA BIOTHERAPEUTICS, INC. proceeds from issuance of convertible preferred stock for fiscal 2013 was $53.38M.
| Period end | Proceeds from Issuance of Convertible Preferred Stock 3 month | Proceeds from Issuance of Convertible Preferred Stock 4 month | Proceeds from Issuance of Convertible Preferred Stock 6 month | Proceeds from Issuance of Convertible Preferred Stock 9 month | Proceeds from Issuance of Convertible Preferred Stock 12 month | Proceeds from Issuance of Convertible Preferred Stock 12 month as first filed |
|---|---|---|---|---|---|---|
| 2016-12-31 | $0.00 10-K · filed 2017-03-09 | |||||
| 2015-12-31 | $0.00 10-K · filed 2017-03-09 | |||||
| 2014-12-31 | -$19.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | -$19.00K derived: sum of 2 quarters · filed 2017-03-09 | -$19.00K derived: sum of 3 quarters · filed 2017-03-09 | $13.48M 10-K · filed 2017-03-09 | $13.50M 10-K · filed 2015-02-26 | |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $0.00 derived: sum of 2 quarters · filed 2015-11-06 | $13.50M 10-Q · filed 2015-11-06 | $51.79M derived: sum of 4 quarters · filed 2016-03-04 | ||
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $13.50M 10-Q · filed 2015-08-07 | $51.79M derived: sum of 3 quarters · filed 2016-03-04 | |||
| 2014-03-31 | $13.50M 10-Q · filed 2015-05-11 | $51.79M derived: sum of 2 quarters · filed 2016-03-04 | ||||
| 2013-12-31 | $38.29M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-04 | $53.38M 10-K · filed 2016-03-04 | $53.59M 10-K · filed 2015-02-26 | |||
| 2013-09-30 | $15.09M 10-Q · filed 2014-11-12 | |||||
| 2012-12-31 | $5.00M 10-K · filed 2015-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |